Protagenic Therapeutics, Inc.\new Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Protagenic Therapeutics, Inc.\new (PTIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 742.15 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-03-31
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 0.00 shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 0.00 shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 742.15K shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 742.15K shares.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 12.50K shares, a 91.42% decline from fiscal 2021.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 145.75K shares, a 91.73% decline from fiscal 2020.
- Protagenic Therapeutics, Inc.\new share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 1.76M shares, a 1292.54% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-31 | 0.00 shares derived: sum of 3 quarters · filed 2025-03-31 | 742.15K shares 10-K · filed 2025-03-31 | ||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 742.15K shares 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 742.15K shares 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | 742.15K shares 10-Q · filed 2024-05-15 | |||||
| 2022-12-31 | -37.50K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | -37.50K shares derived: sum of 2 quarters · filed 2024-05-14 | -37.50K shares derived: sum of 3 quarters · filed 2024-05-14 | 12.50K shares 10-K/A · filed 2024-05-14 | ||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-14 | 50.00K shares 10-Q · filed 2022-11-14 | -387.25K shares derived: sum of 4 quarters · filed 2023-03-31 | ||
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 50.00K shares 10-Q · filed 2022-08-11 | -387.25K shares derived: sum of 3 quarters · filed 2023-03-31 | -350.25K shares derived: sum of 4 quarters · filed 2023-03-31 | ||
| 2022-03-31 | 50.00K shares 10-Q · filed 2022-05-13 | -387.25K shares derived: sum of 2 quarters · filed 2023-03-31 | -350.25K shares derived: sum of 3 quarters · filed 2023-03-31 | -170.25K shares derived: sum of 4 quarters · filed 2023-03-31 | ||
| 2021-12-31 | -437.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -400.25K shares derived: sum of 2 quarters · filed 2023-03-31 | -220.25K shares derived: sum of 3 quarters · filed 2023-03-31 | 145.75K shares 10-K · filed 2023-03-31 | 583.00K shares 10-K · filed 2022-04-07 | |
| 2021-09-30 | 37.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 217.00K shares derived: sum of 2 quarters · filed 2021-11-15 | 583.00K shares 10-Q · filed 2021-11-15 | 583.00K shares derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2021-06-30 | 180.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 546.00K shares 10-Q · filed 2021-08-16 | 546.00K shares derived: sum of 3 quarters · filed 2021-08-16 | 921.00K shares derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2021-03-31 | 366.00K shares 10-Q · filed 2021-05-17 | 366.00K shares derived: sum of 2 quarters · filed 2021-05-17 | 741.00K shares derived: sum of 3 quarters · filed 2021-05-17 | 741.00K shares derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 375.00K shares derived: sum of 2 quarters · filed 2021-03-25 | 375.00K shares derived: sum of 3 quarters · filed 2021-03-25 | 1.76M shares 10-K · filed 2021-03-25 | ||
| 2020-09-30 | 375.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | 375.00K shares derived: sum of 2 quarters · filed 2020-11-16 | 1.76M shares 10-Q · filed 2020-11-16 | 1.76M shares derived: sum of 4 quarters · filed 2021-03-25 | ||
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | 1.39M shares 10-Q · filed 2020-08-14 | 1.39M shares derived: sum of 3 quarters · filed 2021-03-25 | 1.39M shares derived: sum of 4 quarters · filed 2021-03-25 | ||
| 2020-03-31 | 1.39M shares 10-Q · filed 2020-06-18 | 1.39M shares derived: sum of 2 quarters · filed 2021-03-25 | 1.39M shares derived: sum of 3 quarters · filed 2021-03-25 | 1.41M shares derived: sum of 4 quarters · filed 2021-03-25 | ||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-25 | 25.00K shares derived: sum of 3 quarters · filed 2021-03-25 | 126.57K shares 10-K · filed 2021-03-25 | ||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 25.00K shares derived: sum of 2 quarters · filed 2019-11-14 | 126.57K shares 10-Q · filed 2019-11-14 | 126.57K shares derived: sum of 4 quarters · filed 2020-04-29 | ||
| 2019-06-30 | 25.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 126.57K shares 10-Q · filed 2019-08-14 | 126.57K shares derived: sum of 3 quarters · filed 2020-04-29 | 126.57K shares derived: sum of 4 quarters · filed 2020-04-29 | ||
| 2019-03-31 | 101.57K shares 10-Q · filed 2019-05-16 | 101.57K shares derived: sum of 2 quarters · filed 2020-04-29 | 101.57K shares derived: sum of 3 quarters · filed 2020-04-29 | 101.57K shares derived: sum of 4 quarters · filed 2020-04-29 | ||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | 0.00 shares derived: sum of 2 quarters · filed 2020-04-29 | 0.00 shares derived: sum of 3 quarters · filed 2020-04-29 | 280.00K shares 10-K · filed 2020-04-29 | ||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-08 | 280.00K shares 10-Q · filed 2018-11-08 | 1.23M shares derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 280.00K shares 10-Q · filed 2018-08-14 | 1.23M shares derived: sum of 3 quarters · filed 2019-03-29 | 1.23M shares derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2018-03-31 | 280.00K shares 10-Q · filed 2018-05-15 | 1.23M shares derived: sum of 2 quarters · filed 2019-03-29 | 1.23M shares derived: sum of 3 quarters · filed 2019-03-29 | 1.23M shares derived: sum of 4 quarters · filed 2019-03-29 | ||
| 2017-12-31 | 953.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | 953.00K shares derived: sum of 2 quarters · filed 2019-03-29 | 953.00K shares derived: sum of 3 quarters · filed 2019-03-29 | 1.10M shares 10-K · filed 2019-03-29 | ||
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-13 | 150.00K shares 10-Q · filed 2017-11-13 | -516.14K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 150.00K shares 10-Q · filed 2017-08-08 | -516.14K shares derived: sum of 3 quarters · filed 2018-04-02 | 157.22K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-03-31 | 150.00K shares 10-Q · filed 2017-05-15 | -516.14K shares derived: sum of 2 quarters · filed 2018-04-02 | 157.22K shares derived: sum of 3 quarters · filed 2018-04-02 | 1.30M shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2016-12-31 | -666.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 7.22K shares derived: sum of 2 quarters · filed 2018-04-02 | 1.15M shares derived: sum of 3 quarters · filed 2018-04-02 | 1.31M shares 10-K · filed 2018-04-02 | ||
| 2016-09-30 | 673.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-17 | 1.81M shares derived: sum of 2 quarters · filed 2016-11-17 | 1.97M shares 10-Q · filed 2016-11-17 | |||
| 2016-06-30 | 1.14M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | 1.30M shares 10-Q · filed 2016-08-15 | ||||
| 2016-03-31 | 161.58K shares 10-Q · filed 2017-05-15 | 100.00K shares 10-Q · filed 2016-07-25 | ||||
| 2015-12-31 | 490.00K shares 8-K/A · filed 2016-07-12 | |||||
| 2014-12-31 | 240.00K shares 8-K/A · filed 2016-07-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |